Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during viral infections, chronic type I and II IFN signaling can lead to immune suppression and a failure to clear viral infection.51-53”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Interferon-stimulated genes and their antiviral effector functions
Schoggins, J. W., & Rice, C. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.008 · Cited by 1,289
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Self-citationIMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Ahmed, R., Salmi, A., Butler, L. D., Chiller, J. M., & Oldstone, M. B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.521 · Cited by 792
Self-citationDeeks, S. G., & Walker, B. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.010 · Cited by 759
Immune activation and inflammation in HIV‐1 infection: causes and consequences
Appay, V, & Sauce, D. (2008) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 743
T‐cell exhaustion: characteristics, causes and conversion
Yi, J. S., Cox, M. A., & Zajac, A. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03255.x · Cited by 645
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 481
Bosinger, S. E., Li, Q., Gordon, S. N., Klatt, N. R., Duan, L., Xu, L., Francella, N., Sidahmed, A., Smith, A. J., Cramer, E. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40115 · Cited by 409
Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
Zeng, M., Smith, A. J., Wietgrefe, S. W., Southern, P. J., Schacker, T. W., Reilly, C. S., Estes, J. D., Burton, G. F., Silvestri, G., Lifson, J. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45157 · Cited by 309
Borrow, P., Evans, C. F., & Oldstone, M. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1059-1070.1995 · Cited by 291
Self-citationImmunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
Sevilla, N., Kunz, S., Holz, A., Lewicki, H., Homann, D., Yamada, H., Campbell, K. P., de la Torre, J. C., & Oldstone, M. B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1249 · Cited by 287
Self-citationSheehan, K. C. F., Lai, K. S., Dunn, G. P., Bruce, A. T., Diamond, M. S., Heutel, J. D., Dungo-Arthur, C., Carrero, J. A., White, J. M., Hertzog, P. J., et al. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.804 · Cited by 260
Self-citationHahm, B., Trifilo, M. J., Zuniga, E. I., & Oldstone, M. B. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.005 · Cited by 210
Self-citationSalvato, M., Borrow, P., Shimomaye, E., & Oldstone, M. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1863-1869.1991 · Cited by 187
Self-citationZeng, M., Southern, P. J., Reilly, C. S., Beilman, G. J., Chipman, J. G., Schacker, T. W., & Haase, A. T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002437 · Cited by 182
Sevilla, N., McGavern, D. B., Teng, C., Kunz, S., & Oldstone, M. B. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420243 · Cited by 172
Self-citationSullivan, B. M., Emonet, S. F., Welch, M. J., Lee, A. M., Campbell, K. P., de la Torre, J. C., & Oldstone, M. B. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019304108 · Cited by 132
Self-citationScheu, S., Dresing, P., & Locksley, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808537105 · Cited by 130
HIV-Associated Immune Activation: From Bench to Bedside
d’Ettorre, G., Paiardini, M., Ceccarelli, G., Silvestri, G., & Vullo, V. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0342 · Cited by 126
Bergthaler, A., Flatz, L., Hegazy, A. N., Johnson, S., Horváth, E. J., Löhning, M., & Pinschewer, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011998107 · Cited by 121
HIV controllers: how do they tame the virus?
Sáez‐Cirión, A., Pancino, G., Sinet, M., Venet, A., & Lambotte, O. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.002 · Cited by 99
Oldstone, M. B. A., & Campbell, K. P. (2010) · Virology · doi:10.1016/j.virol.2010.11.023 · Cited by 93
Self-citationInnate Immune Activation in Primary HIV‐1 Infection
Chang, J. J., & Altfeld, M. A. (2010) · The Journal of Infectious Diseases · doi:10.1086/655657 · Cited by 88
Macal, M., Lewis, G. M., Kunz, S., Flavell, R. A., Harker, J. A., & Zúñiga, E. I. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.017 · Cited by 85
Lymphotoxin-β-Deficient Mice Show Defective Antiviral Immunity
Berger, D. P., Naniche, D., Crowley, M. T., Koni, P. A., Flavell, R. A., & Oldstone, M. B. A. (1999) · Virology · doi:10.1006/viro.1999.9811 · Cited by 71
Self-citationRole of an Intact Splenic Microarchitecture in Early Lymphocytic Choriomeningitis Virus Production
Müller, S., Hunziker, L., Enzler, S., Bühler-Jungo, M., Di Santo, J. P., Zinkernagel, R. M., & Mueller, C. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2375-2383.2002 · Cited by 54
Role of Lymphotoxin α in T-Cell Responses during an Acute Viral Infection
Suresh, M., Lanier, G., Large, M. K., Whitmire, J. K., Altman, J. D., Ruddle, N. H., & Ahmed, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3943-3951.2002 · Cited by 50
Resolution of immune activation defines nonpathogenic SIV infection
Manches, O., & Bhardwaj, N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci41509 · Cited by 45
Evans, C. F., Borrow, P., de la Torre, J. C., & Oldstone, M. B. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7367-7373.1994 · Cited by 44
Self-citation
Cited by
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
“Other genes include interferon stimulated genes, which may promote immune suppression through PD-L1 10,11 .”
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Metadata
- Authors
- Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A.
- Affiliations
- Scripps Research Institute (US)
- Washington University in St. Louis (US)
- Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Corresponding author
- Teijaro, John R.
- Ng, Cherie
- Oldstone, Michael B. A.
- ORCID
- Venue
- Science
- Published
- 2013-04-12
- Volume
- 340
- Issue
- 6129
- Pages
- 207-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3640797
- OpenAlex
- W2024556668
- Cited by
- 755
- References
- 38
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 39 · 2023: 40 · 2022: 42 · 2021: 49 · 2020: 56 · 2019: 55 · 2018: 55 · 2017: 73 · 2016: 86 · 2015: 80 · 2014: 71 · 2013: 37
- FWCI
- 50.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5t32ns041219-10, 5t32ai007354-30)
- National Heart, Lung, and Blood Institute (HL007195, T32HL007195)
- National Cancer Institute (R01CA043059, CA-43059, R37CA043059)
- National Institute of Allergy and Infectious Diseases (AI-077719, AI09484, AI-047140, R01AI009484, AI007354, R01AI047140, T32-AI007354., R56AI077719, R01AI077719, U54AI057160)
- National Institute of Neurological Disorders and Stroke (T32-NS041219, NS-041219)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- lymphocytic choriomeningitis virus, viral persistence, type I interferon signaling, immune activation, negative immune regulation, CD4+ T cells, viral clearance, antiviral therapy
- MeSH terms
- Animals, Antibodies, Viral, Arenaviridae Infections, Dendritic Cells, Female, Immune Tolerance, Interferon Type I, Lymphocytes, Lymphocytic choriomeningitis virus, Male, Mice, Inbred C57BL, Spleen, Viremia, Signal Transduction, CD4-Positive T-Lymphocytes, Cytokines, Interleukin-10, Mice, Receptor, Interferon alpha-beta, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.